138 related articles for article (PubMed ID: 24473321)
1. A cistrome roadmap for understanding pancreatic islet biology.
Avrahami D; Kaestner KH
Nat Genet; 2014 Feb; 46(2):95-6. PubMed ID: 24473321
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants.
Pasquali L; Gaulton KJ; Rodríguez-Seguí SA; Mularoni L; Miguel-Escalada I; Akerman İ; Tena JJ; Morán I; Gómez-Marín C; van de Bunt M; Ponsa-Cobas J; Castro N; Nammo T; Cebola I; García-Hurtado J; Maestro MA; Pattou F; Piemonti L; Berney T; Gloyn AL; Ravassard P; Skarmeta JLG; Müller F; McCarthy MI; Ferrer J
Nat Genet; 2014 Feb; 46(2):136-143. PubMed ID: 24413736
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk.
Greenwald WW; Chiou J; Yan J; Qiu Y; Dai N; Wang A; Nariai N; Aylward A; Han JY; Kadakia N; Regue L; Okino ML; Drees F; Kramer D; Vinckier N; Minichiello L; Gorkin D; Avruch J; Frazer KA; Sander M; Ren B; Gaulton KJ
Nat Commun; 2019 May; 10(1):2078. PubMed ID: 31064983
[TBL] [Abstract][Full Text] [Related]
4. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes.
Miguel-Escalada I; Bonàs-Guarch S; Cebola I; Ponsa-Cobas J; Mendieta-Esteban J; Atla G; Javierre BM; Rolando DMY; Farabella I; Morgan CC; García-Hurtado J; Beucher A; Morán I; Pasquali L; Ramos-Rodríguez M; Appel EVR; Linneberg A; Gjesing AP; Witte DR; Pedersen O; Grarup N; Ravassard P; Torrents D; Mercader JM; Piemonti L; Berney T; de Koning EJP; Kerr-Conte J; Pattou F; Fedko IO; Groop L; Prokopenko I; Hansen T; Marti-Renom MA; Fraser P; Ferrer J
Nat Genet; 2019 Jul; 51(7):1137-1148. PubMed ID: 31253982
[TBL] [Abstract][Full Text] [Related]
5. Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition.
Perez-Alcantara M; Honoré C; Wesolowska-Andersen A; Gloyn AL; McCarthy MI; Hansson M; Beer NL; van de Bunt M
Diabetologia; 2018 Jul; 61(7):1614-1622. PubMed ID: 29675560
[TBL] [Abstract][Full Text] [Related]
6. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.
van de Bunt M; Gaulton KJ; Parts L; Moran I; Johnson PR; Lindgren CM; Ferrer J; Gloyn AL; McCarthy MI
PLoS One; 2013; 8(1):e55272. PubMed ID: 23372846
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Islet Transcriptional Enhancers and Diabetes.
Cebola I
Curr Diab Rep; 2019 Nov; 19(12):145. PubMed ID: 31754873
[TBL] [Abstract][Full Text] [Related]
8. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Viñuela A; Varshney A; van de Bunt M; Prasad RB; Asplund O; Bennett A; Boehnke M; Brown AA; Erdos MR; Fadista J; Hansson O; Hatem G; Howald C; Iyengar AK; Johnson P; Krus U; MacDonald PE; Mahajan A; Manning Fox JE; Narisu N; Nylander V; Orchard P; Oskolkov N; Panousis NI; Payne A; Stitzel ML; Vadlamudi S; Welch R; Collins FS; Mohlke KL; Gloyn AL; Scott LJ; Dermitzakis ET; Groop L; Parker SCJ; McCarthy MI
Nat Commun; 2020 Sep; 11(1):4912. PubMed ID: 32999275
[TBL] [Abstract][Full Text] [Related]
9. Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits.
Hudaiberdiev S; Taylor DL; Song W; Narisu N; Bhuiyan RM; Taylor HJ; Tang X; Yan T; Swift AJ; Bonnycastle LL; Consortium D; Chen S; Stitzel ML; Erdos MR; Ovcharenko I; Collins FS
Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2206612120. PubMed ID: 37603758
[TBL] [Abstract][Full Text] [Related]
10. Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis.
Volkov P; Bacos K; Ofori JK; Esguerra JL; Eliasson L; Rönn T; Ling C
Diabetes; 2017 Apr; 66(4):1074-1085. PubMed ID: 28052964
[TBL] [Abstract][Full Text] [Related]
11. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes.
Aylward A; Okino ML; Benaglio P; Chiou J; Beebe E; Padilla JA; Diep S; Gaulton KJ
PLoS Genet; 2021 May; 17(5):e1009531. PubMed ID: 33983929
[TBL] [Abstract][Full Text] [Related]
13. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci.
Stitzel ML; Sethupathy P; Pearson DS; Chines PS; Song L; Erdos MR; Welch R; Parker SC; Boyle AP; Scott LJ; ; Margulies EH; Boehnke M; Furey TS; Crawford GE; Collins FS
Cell Metab; 2010 Nov; 12(5):443-55. PubMed ID: 21035756
[TBL] [Abstract][Full Text] [Related]
14. Single-cell ATAC-Seq in human pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures.
Rai V; Quang DX; Erdos MR; Cusanovich DA; Daza RM; Narisu N; Zou LS; Didion JP; Guan Y; Shendure J; Parker SCJ; Collins FS
Mol Metab; 2020 Feb; 32():109-121. PubMed ID: 32029221
[TBL] [Abstract][Full Text] [Related]
15. Genetic regulation of RNA splicing in human pancreatic islets.
Atla G; Bonàs-Guarch S; Cuenca-Ardura M; Beucher A; Crouch DJM; Garcia-Hurtado J; Moran I; ; Irimia M; Prasad RB; Gloyn AL; Marselli L; Suleiman M; Berney T; de Koning EJP; Kerr-Conte J; Pattou F; Todd JA; Piemonti L; Ferrer J
Genome Biol; 2022 Sep; 23(1):196. PubMed ID: 36109769
[TBL] [Abstract][Full Text] [Related]
16. Genetic risk converges on regulatory networks mediating early type 2 diabetes.
Walker JT; Saunders DC; Rai V; Chen HH; Orchard P; Dai C; Pettway YD; Hopkirk AL; Reihsmann CV; Tao Y; Fan S; Shrestha S; Varshney A; Petty LE; Wright JJ; Ventresca C; Agarwala S; Aramandla R; Poffenberger G; Jenkins R; Mei S; Hart NJ; Phillips S; Kang H; Greiner DL; Shultz LD; Bottino R; Liu J; Below JE; ; Parker SCJ; Powers AC; Brissova M
Nature; 2023 Dec; 624(7992):621-629. PubMed ID: 38049589
[TBL] [Abstract][Full Text] [Related]
17. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.
Lawlor N; George J; Bolisetty M; Kursawe R; Sun L; Sivakamasundari V; Kycia I; Robson P; Stitzel ML
Genome Res; 2017 Feb; 27(2):208-222. PubMed ID: 27864352
[TBL] [Abstract][Full Text] [Related]
18. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of type II diabetes mellitus and maturity onset diabetes of young pathways in human pancreatic islets from hyperglycemic donors.
Taneera J; Storm P; Groop L
J Diabetes Res; 2014; 2014():237535. PubMed ID: 25379510
[TBL] [Abstract][Full Text] [Related]
20. ATAC-seq reveals alterations in open chromatin in pancreatic islets from subjects with type 2 diabetes.
Bysani M; Agren R; Davegårdh C; Volkov P; Rönn T; Unneberg P; Bacos K; Ling C
Sci Rep; 2019 May; 9(1):7785. PubMed ID: 31123324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
